XML 36 R24.htm IDEA: XBRL DOCUMENT v3.19.1
SEGMENT INFORMATION
3 Months Ended
Mar. 31, 2019
SEGMENT INFORMATION  
SEGMENT INFORMATION

NOTE 16 – SEGMENT INFORMATION

We are organized into three reporting segments.  Operations that sell dispensing systems and sealing solutions primarily to the personal care, beauty and home care markets form the Beauty + Home segment.  Operations that sell dispensing systems, sealing and active packaging solutions primarily to the prescription drug, consumer health care and injectables markets form the Pharma segment.  Operations that sell dispensing systems and sealing solutions primarily to the food and beverage markets form the Food + Beverage segment.

The accounting policies of the segments are the same as those described in Part II, Item 8, Note 1 - Summary of Significant Accounting Policies in our Annual Report on Form 10-K for the year ended December 31, 2018.  We evaluate performance of our business units and allocate resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring and acquisition-related costs.

All internal segment reporting and discussions of results with our Chief Operating Decision Maker (CODM) are based on segment Adjusted EBITDA.

Financial information regarding our reporting segments is shown below:

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

    

2019

 

2018

 

Total Sales:

 

 

 

 

 

 

 

Beauty + Home

 

$

373,503

 

$

383,463

   

Pharma

 

 

274,494

 

 

230,132

 

Food + Beverage

 

 

104,727

 

 

95,645

 

Total Sales

 

$

752,724

 

$

709,240

 

Less: Intersegment Sales:

 

 

 

 

 

 

 

Beauty + Home

 

$

5,844

 

$

5,290

 

Pharma

 

 

1,793

 

 

 5

 

Food + Beverage

 

 

627

 

 

595

 

Total Intersegment Sales

 

$

8,264

 

$

5,890

 

Net Sales:

 

 

 

 

 

 

 

Beauty + Home

 

$

367,659

 

$

378,173

 

Pharma

 

 

272,701

 

 

230,127

 

Food + Beverage

 

 

104,100

 

 

95,050

 

Net Sales

 

$

744,460

 

$

703,350

 

Adjusted EBITDA:

 

 

 

 

 

 

 

Beauty + Home

 

$

53,191

 

$

53,135

 

Pharma

 

 

97,357

 

 

79,840

 

Food + Beverage

 

 

16,691

 

 

12,739

 

Corporate & Other, unallocated

 

 

(12,755)

 

 

(11,579)

 

Restructuring Initiatives (1)

 

 

(9,530)

 

 

(5,936)

 

Depreciation and amortization

 

 

(47,489)

 

 

(41,175)

 

Interest Expense

 

 

(9,214)

 

 

(8,055)

 

Interest Income

 

 

1,748

 

 

2,248

 

Income before Income Taxes

 

$

89,999

 

$

81,217

 


(1)

Restructuring Initiatives includes expense items for the three months ended March 31, 2019 and 2018 as follows (see Note 19 – Restructuring Initiatives for further details):

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

2019

    

2018

 

Restructuring Initiatives by Segment

 

 

 

 

 

 

 

Beauty + Home

 

$

8,269

 

$

5,016

 

Pharma

 

 

326

 

 

364

 

Food + Beverage

 

 

510

 

 

315

 

Corporate & Other

 

 

425

 

 

241

 

Total Restructuring Initiatives

 

$

9,530

 

$

5,936